Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Nicotinamide mononucleotide
by Most Patent Citation in the China in 2018

The Nicotinamide mononucleotide top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Citation Nicotinamide mononucleotide Key Players in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Nicotinamide mononucleotide ("NMN", "NAMN", and "β-NMN") is a nucleotide derived from ribose and nicotinamide. Like nicotinamide riboside, NMN is a derivative of niacin, and humans have enzymes that can use NMN to generate nicotinamide adenine dinucleotide (NADH).
#
Company Name
Region
Tech Topics
Total
1
patent citation: 27
2
patent citation: 5
3
patent citation: 5
4
patent citation: 4
5
patent citation: 2
6
Health care,Research system,International health,
...[+2]
patent citation: 2
7
patent citation: 2
8
Plasma Volume Expander,Antibiotics,Drug,
...[+1]
patent citation: 2
9
patent citation: 2
10
Nutrition,Health care,Arachidonic acid,
...[+2]
patent citation: 1
11
patent citation: 1
12
patent citation: 1
13
patent citation: 1
14
Zhongke Health Industry Group Corp., Ltd
patent citation: 1
15
Medicine,Bead,Cardiovascular agent,
...[+2]
patent citation: 0
16
patent citation: 0
17
Health care,Genetic engineering,Enzyme,
...[+2]
patent citation: 0
18
patent citation: 0
19
patent citation: 0
20
patent citation: 0
Page generation time: Jun 20 2025